trevor bachmeyer retatrutide dosage Episodes Why Semaglutide & Tirzepatide Can't

Many patients living with the disease of obesity have an unhealthy relationship with the scales

Nearly two-thirds say their shopping habits have changed since they began taking a GLP-1 medication for weight loss

Studies also report improvements in metabolic markers, including HbA1c and lipid profiles, positioning Retatrutide as one of the most promising future therapies for obesity and type 2 diabetes, However it remains unapproved and is still in Phase 3 trials, with expected regulatory decisions around 20262027

In rodents, modulation of GLP-1R activity can influence amyloid-beta peptide aggregation in Alzheimers disease (63) and dopamine levels in Parkinson's disease (64)

Under the Dietary Supplement Health and Education Act (DSHEA), these products can only make structure/function claims (not disease claims) and must carry a disclaimer stating that they have not been evaluated by the FDA